Global Stock News

Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products

Article feature image

Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products

RIVERDALE, Md., Aug. 12, 2021 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, today announced it has raised $7.4 million in private equity to support its growing product line and development of its lead surgical candidate for clinical…

Click here to view the original article.

Share this article

Scroll to Top